ATI Holdings, LLC
NYSE ATI · Dallas, TX
Works in Hematology · Musculoskeletal · Neurology
ATI Holdings, LLC is a clinical trial sponsor based in Dallas, TX, listed as NYSE ATI. It has 2 active clinical trials with 4,550,000 planned participants, in Hematology, Musculoskeletal and Neurology.
Trial track record · since 2021
Financials · NYSE ATI
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about ATI Holdings, LLC
ATI Holdings, LLC is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 4,550,000 planned participants, in Hematology, Musculoskeletal, Neurology. Since 2021 it has completed 0 trials and stopped 0 early.
ATI Holdings, LLC is based in Dallas, TX and is listed as NYSE ATI. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with ATI Holdings, LLC; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-05-04.
Approve Suite is not affiliated with ATI Holdings, LLC. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.